Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2013

View Archived Issues

Development of a targeted immunotoxin for the destruction of brain cancer cells in glioblastomas

First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis

PTC Therapeutics identifies novel fused 2-pyridones active against resistant bacteria

Discovery of novel cathepsin K inhibitors for bone resorption

Viriom reports data from international trial of HIV drug candidate

Continued clinical benefit of tildrakizumab for 1 year in chronic psoriasis

2B3-201 as a strategy for sustained and nontoxic release of methylprednisolone

Bharat Biotech launches inactivated Japanese encephalitis vaccine

Boost to MAX BioPharma's oxysterol program through licensing and SBIR grant

Almac Discovery patent describes novel protein kinase Akt inhibitors

Bristol-Myers Squibb prepares and tests HIV attachment inhibitors

Liver X receptor-beta agonists reported in Vitae Pharmaceuticals patent

Minerva Patents presents compound for ischemic reperfusion injury

Bayer selects drug candidates for accelerated development and expands indications for approved drugs

FDA accepts filing of Zerenex NDA

Janssen acquires NS5A inhibitor from GlaxoSmithKline for hepatitis C

University of Queensland and Leo Pharma form strategic skin cancer collaboration

Edimer begins phase II trial in XLHED-affected male newborns

Pfizer in-licenses preclinical program on early-onset morbid obesity

GSK reports results from large-scale phase III trial of malaria vaccine RTS,S

Active Biotech receives milestone payment for tasquinimod trial

FDA approves Adempas for CTEPH and PAH

Hutchison MediPharma and Eli Lilly sign agreement for fruquintinib

Forma Therapeutics meets first objective in collaboration with Celgene

ILC receives orphan drug designation in Europe for osteosarcoma

VAC-3S vaccine: first-in-human safety, dose and immunization results

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...